6-minute walk distance (predicted)

Clinical background

The six-minute walk test (6MWT) measures the distance a patient can cover in six minutes at a self-selected pace on level ground. It is a submaximal, self-paced field test reflecting integrated cardiopulmonary, muscular and autonomic function. Unlike cardiopulmonary exercise testing it requires no advanced equipment, but unlike laboratory tests the result is influenced by motivation, gait pattern and external factors such as the length of the walking course and the encouragement given.

The clinical decision that the reference equations serve is whether a measured walk distance is normal or abnormally low for the patient's sex, age, height and weight. Without a population-specific reference, one risks either overlooking appreciable functional impairment or classifying an age-appropriate decline as pathological. A predicted walk distance also makes it possible to express the result as a percentage of predicted, which facilitates comparison over time and between patients.

Calculating the 6-minute walk distance

The calculator uses the regression equations of Enright and Sherrill from 1998 [1]:

Men: $$\text{6MWD} = 7{.}57 \times \text{height}$${\text{cm}} - 5{.}02 \times \text{age} - 1{.}76 \times \text{weight}{\text{kg}} - 309

Women: $$\text{6MWD} = 2{.}11 \times \text{height}$${\text{cm}} - 2{.}29 \times \text{weight}{\text{kg}} - 5{.}78 \times \text{age} + 667

The lower limit of normal is expressed as the predicted value minus 153 m for men and minus 139 m for women, which approximates the fifth percentile in the derivation cohort.

The derivation cohort consisted of 117 healthy men and 173 healthy women aged 40 to 80 years, all of whom performed a standardised 6MWT according to the ATS protocol at the University of Arizona [1]. The median walk distance was 576 m for men and 494 m for women. The regression models explained about 40 per cent of the variance in walk distance, meaning that 60 per cent is due to factors outside the model: level of physical activity, motivation, gait pattern and other anthropometric characteristics. This is important to bear in mind when interpreting deviations from the predicted value.

Interpretation in practice

The predicted value indicates what a healthy person of the same sex, age, height and weight would be expected to achieve. Clinical interpretation rests on the ratio of measured to predicted walk distance, with the lower limit of normal as an aid to setting the boundary:

A fall in the 6MWD of about 30 m or more on repeat testing can in itself be regarded as clinically meaningful in patients with chronic respiratory disease [4]. Note, however, that the threshold for a clinically relevant change varies between diagnoses and that a learning effect on first testing may produce a systematic increase on repetition.

Validation and performance

The Enright equations are one of the most widely cited reference standards for the 6MWD, but they are far from universal. On the contrary, repeated studies in different populations have shown that geographically and ethnically specific reference values are necessary to avoid systematic misclassification.

In a comparative study of healthy adults in Belgium (n = 239) and Vietnam (n = 303), aged 18 to 80 years, the mean walk distance was 625 m and 449 m respectively, a difference of 176 m that persisted after adjustment for age and sex [2]. The difference is explained by anthropometry, BMI, level of physical activity and culturally determined gait patterns, but the result clearly shows that the same prediction equation cannot be used in different regions without a risk of bias.

In a Singaporean cohort (n = 172, aged 21 to 80), Yeung et al. showed that nine of eleven previously published prediction equations significantly overestimated the 6MWD when applied to their population [3]. Only one of eleven equations gave a result that did not differ statistically significantly from the measured distance. Their own Singaporean model explained 58 per cent of the variance, compared with 40 per cent in Enright's original, by including among other things the percentage of predicted maximum heart rate and the heart rate reserve.

In practice this means that the Enright equations, derived in a US cohort in the late 1990s, may overestimate the walk distance in populations of shorter average height, lower BMI or a different level of physical activity. A patient achieving 85 per cent of the Enright-predicted value may in fact be within the normal range for their population, while a patient achieving 100 per cent in a population where the norm is higher may have an impairment that goes unrecognised.

Limitations

The equations apply to adults aged 40 to 80 years. The calculator's range permits 40 to 100 years, but extrapolation to patients over 80 has no empirical basis in the derivation cohort. For younger adults under 40 years there is no validated prediction in the Enright equations, and other reference material may be needed.

A straightforward clinical pitfall is to interpret a low result as evidence of a specific diagnosis. The 6MWD is a non-specific measure of global walking ability and may be reduced in heart failure, COPD, interstitial lung disease, pulmonary arterial hypertension, neuromuscular disease, general debility, pain, an unsuitable walking course and poor motivation. A subnormal result justifies further investigation, not a diagnosis.

The conduct of the test itself influences the result at least as much as patient factors. According to the 2002 ATS guidelines, the walking course should be at least 30 m long with cones at the turning points, standardised encouragement should be given every minute, and the patient should be instructed to walk as far as possible without running [5]. A shorter course, a lack of standardised encouragement or a patient who has not understood the instruction may systematically underestimate the walk distance. At baseline assessment, two test sessions with at least 30 minutes' rest between them are recommended, since a learning effect of up to about 2 per cent may be seen on the second test [3,4]. For repeated measurements during treatment or rehabilitation, a single test may suffice if the patient is already familiar with it.

In patients on beta blockers or with chronotropic incompetence, heart rate measurement and the percentage of predicted maximum heart rate may be misleading, which is a further reason not to over-interpret individual physiological variables during the test.

References

1. Enright PL, Sherrill DL. Reference equations for the 6-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384–7. PMID: 9817683
2. Nguyen DT, Penta M, Questienne C et al. Normative values in healthy adults for the 6-minute and 2-minute walk tests in Belgium and Vietnam: implications for clinical practice. J Rehabil Med 2024;56:18628. PMID: 38501732
3. Yeung MT, Chan MY, Huang KS et al. Normative reference values and regression equations to predict the 6-minute walk distance in the Asian adult population aged 21–80 years. Hong Kong Physiother J 2022;42(2):111–124. PMID: 37560171
4. Puente-Maestu L, Palange P, Casaburi R et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 2016;47(2):429–60. PMID: 26797036
5. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111–7. PMID: 12091180